Suppr超能文献

鉴定具有不同T细胞抑制活性的离散肿瘤诱导的髓源性抑制细胞亚群。

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

作者信息

Movahedi Kiavash, Guilliams Martin, Van den Bossche Jan, Van den Bergh Rafael, Gysemans Conny, Beschin Alain, De Baetselier Patrick, Van Ginderachter Jo A

机构信息

Laboratory of Cellular and Molecular Immunology, Department of Molecular and Cellular Interactions, VIB, Brussels, Belgium.

出版信息

Blood. 2008 Apr 15;111(8):4233-44. doi: 10.1182/blood-2007-07-099226. Epub 2008 Feb 13.

Abstract

The induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) is an important immune-evading mechanism used by tumors. However, the exact nature and function of MDSCs remain elusive, especially because they constitute a heterogeneous population that has not yet been clearly defined. Here, we identified 2 distinct MDSC subfractions with clear morphologic, molecular, and functional differences. These fractions consisted of either mononuclear cells (MO-MDSCs), resembling inflammatory monocytes, or low-density polymorphonuclear cells (PMN-MDSCs), akin to immature neutrophils. Interestingly, both MO-MDSCs and PMN-MDSCs suppressed antigen-specific T-cell responses, albeit using distinct effector molecules and signaling pathways. Blocking IFN-gamma or disrupting STAT1 partially impaired suppression by MO-MDSCs, for which nitric oxide (NO) was one of the mediators. In contrast, while IFN-gamma was strictly required for the suppressor function of PMN-MDSCs, this did not rely on STAT1 signaling or NO production. Finally, MO-MDSCs were shown to be potential precursors of highly antiproliferative NO-producing mature macrophages. However, distinct tumors differentially regulated this inherent MO-MDSC differentiation program, indicating that this phenomenon was tumor driven. Overall, our data refine tumor-induced MDSC functions by uncovering mechanistically distinct MDSC subpopulations, potentially relevant for MDSC-targeted therapies.

摘要

诱导CD11b(+)Gr-1(+)髓源性抑制细胞(MDSCs)是肿瘤所采用的一种重要免疫逃逸机制。然而,MDSCs的确切性质和功能仍不清楚,特别是因为它们构成了一个尚未明确界定的异质性群体。在此,我们鉴定出2个具有明显形态、分子和功能差异的MDSC亚群。这些亚群由单核细胞(MO-MDSCs,类似于炎性单核细胞)或低密度多形核细胞(PMN-MDSCs,类似于未成熟中性粒细胞)组成。有趣的是,MO-MDSCs和PMN-MDSCs均能抑制抗原特异性T细胞反应,尽管它们使用不同的效应分子和信号通路。阻断IFN-γ或破坏STAT1会部分削弱MO-MDSCs的抑制作用,其中一氧化氮(NO)是介导因子之一。相比之下,虽然IFN-γ是PMN-MDSCs抑制功能所严格必需的,但这并不依赖于STAT1信号传导或NO生成。最后,MO-MDSCs被证明是高抗增殖性NO生成成熟巨噬细胞的潜在前体。然而,不同肿瘤对这种固有的MO-MDSC分化程序有不同的调节,表明这种现象是由肿瘤驱动的。总体而言,我们的数据通过揭示机制上不同的MDSC亚群,完善了肿瘤诱导的MDSC功能,这可能与针对MDSC的治疗相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验